Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 3
2005 2
2006 4
2007 3
2008 4
2009 4
2010 7
2011 3
2013 1
2014 5
2015 8
2016 7
2017 12
2018 9
2019 10
2020 5
2021 10
2022 10
2023 7
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Results by year

Filters applied: . Clear all
Page 1
Legal Positivism's Internal Morality.
Gallego J. Gallego J. Oxf J Leg Stud. 2022 Dec 21;43(2):456-474. doi: 10.1093/ojls/gqac030. eCollection 2023 Summer. Oxf J Leg Stud. 2022. PMID: 37287905 Free PMC article. Review.
Extracellular Vesicles as Biomarkers in Liver Disease.
Muñoz-Hernández R, Rojas Á, Gato S, Gallego J, Gil-Gómez A, Castro MJ, Ampuero J, Romero-Gómez M. Muñoz-Hernández R, et al. Among authors: gallego j. Int J Mol Sci. 2022 Dec 19;23(24):16217. doi: 10.3390/ijms232416217. Int J Mol Sci. 2022. PMID: 36555854 Free PMC article. Review.
Ductular reaction promotes intrahepatic angiogenesis through Slit2-Roundabout 1 signaling.
Coll M, Ariño S, Martínez-Sánchez C, Garcia-Pras E, Gallego J, Moles A, Aguilar-Bravo B, Blaya D, Vallverdú J, Rubio-Tomás T, Lozano JJ, Pose E, Graupera I, Fernández-Vidal A, Pol A, Bataller R, Geng JG, Ginès P, Fernandez M, Sancho-Bru P. Coll M, et al. Among authors: gallego j. Hepatology. 2022 Feb;75(2):353-368. doi: 10.1002/hep.32140. Epub 2021 Dec 15. Hepatology. 2022. PMID: 34490644 Free PMC article.
Nab-Paclitaxel plus Gemcitabine and FOLFOX in Metastatic Pancreatic Cancer.
Carrato A, Pazo-Cid R, Macarulla T, Gallego J, Jiménez-Fonseca P, Rivera F, Cano MT, Rodriguez-Garrote M, Pericay C, Alés I, Layos L, Graña B, Iranzo V, Gallego I, Garcia-Carbonero R, de Mena IR, Guillén-Ponce C, Aranda E. Carrato A, et al. Among authors: gallego j. NEJM Evid. 2024 Feb;3(2):EVIDoa2300144. doi: 10.1056/EVIDoa2300144. Epub 2024 Jan 23. NEJM Evid. 2024. PMID: 38320486 Clinical Trial.
Role of EpCAM+ CD133+ extracellular vesicles in steatosis to steatohepatitis transition in NAFLD.
Muñoz-Hernández R, Gato S, Gil-Gómez A, Aller R, Rojas A, Morán L, Gallego J, Blázquez-López E, Gallego-Durán R, Montero-Vallejo R, García-Fernández V, Maya-Miles D, Rico MDC, Cubero FJ, Vaquero J, Ampuero J, Bañares R, Romero-Gómez M. Muñoz-Hernández R, et al. Among authors: gallego j. Liver Int. 2023 Sep;43(9):1909-1919. doi: 10.1111/liv.15604. Epub 2023 Jun 8. Liver Int. 2023. PMID: 37288714
Total neoadjuvant therapy with or without aflibercept in rectal cancer: 3-year results of GEMCAD-1402.
Pesántez D, Ten Hoorn S, Machado I, García-Albéniz X, Rodríguez-Salas N, Heredia-Soto V, Viñal D, Pericay C, García-Carbonero R, Losa F, Alonso V, Vera R, Feliu Batlle J, Gallego J, Salud A, Nogué M, Layos L, Montagut C, Capdevila J, Vermeulen L, Maurel J, Fernandez-Martos C. Pesántez D, et al. Among authors: gallego j. J Natl Cancer Inst. 2023 Dec 6;115(12):1497-1505. doi: 10.1093/jnci/djad120. J Natl Cancer Inst. 2023. PMID: 37405857 Clinical Trial.
Current controversies in the management of metastatic colorectal cancer.
Vera R, Alonso V, Gállego J, González E, Guillén-Ponce C, Pericay C, Rivera F, Safont MJ, Valladares-Ayerbes M. Vera R, et al. Among authors: gallego j. Cancer Chemother Pharmacol. 2015 Oct;76(4):659-77. doi: 10.1007/s00280-015-2808-6. Epub 2015 Jun 26. Cancer Chemother Pharmacol. 2015. PMID: 26113053 Review.
Oxaliplatin: results in colorectal carcinoma.
Carrato A, Gallego J, Díaz-Rubio E. Carrato A, et al. Among authors: gallego j. Crit Rev Oncol Hematol. 2002 Oct;44(1):29-44. doi: 10.1016/s1040-8428(01)00192-5. Crit Rev Oncol Hematol. 2002. PMID: 12398998 Review.
The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy.
Jimenez-Fonseca P, Foy V, Raby S, Carmona-Bayonas A, Macía-Rivas L, Arrazubi V, Cacho Lavin D, Hernandez San Gil R, Custodio A, Cano JM, Fernández Montes A, Mirallas O, Macias Declara I, Vidal Tocino R, Visa L, Limón ML, Pimentel P, Martínez Lago N, Sauri T, Martín Richard M, Mangas M, Gil Raga M, Calvo A, Reguera P, Granja M, Martín Carnicero A, Hernández Pérez C, Cerdá P, Gomez Gonzalez L, Garcia Navalon F, Pacheco Barcia V, Gutierrez Abad D, Ruiz Martín M, Weaver J, Mansoor W, Gallego J. Jimenez-Fonseca P, et al. Among authors: gallego j. Ther Adv Med Oncol. 2023 Mar 4;15:17588359231157641. doi: 10.1177/17588359231157641. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 36895850 Free PMC article.
108 results